Search results for "Anticoagulation"
MKSAP Quiz: Evaluation for easy bruising
A 48-year-old woman is evaluated for easy bruising. She has no history of gingival bleeding, menorrhagia, or bleeding following procedures. Following a physical exam and lab studies, what is the most appropriate diagnostic test?
https://acpinternist.org/weekly/archives/2023/03/28/3.htm
28 Mar 2023
Patients with provoked VTE often on anticoagulation longer than recommended
Three variables were associated with receiving anticoagulation for longer than three months after a provoked venous thromboembolism (VTE): direct oral anticoagulant use, history of VTE, and history of myocardial infarction.
https://acpinternist.org/weekly/archives/2022/11/01/4.htm
1 Nov 2022
Long-term anticoagulation after first unprovoked VTE associated with considerable bleeding risk
Results from a systematic review and meta-analysis provide a framework for clinicians and patients to balance the benefits and harms of extended anticoagulation for unprovoked venous thromboembolism (VTE).
https://acpinternist.org/weekly/archives/2021/09/14/4.htm
14 Sep 2021
Patients with atrial fibrillation likely to underestimate bleeding risks of anticoagulants
Women were significantly less likely than men to underestimate their bleeding risk, and a history of bleeding was associated with a threefold increased likelihood of inaccurate perception of bleeding risk, according to a study of atrial fibrillation patients.
https://acpinternist.org/weekly/archives/2021/08/24/2.htm
24 Aug 2021
Intervention targeting clinicians did not increase anticoagulation use in patients with afib
Electronic messaging and academic detailing improved clinicians' comfort with prescribing anticoagulation in certain situations, but rates of appropriate anticoagulation for atrial fibrillation did not change significantly, a trial found.
https://acpinternist.org/weekly/archives/2020/02/25/4.htm
25 Feb 2020
Use of warfarin down, DOACs up in commercially insured patients with cirrhosis, nonvalvular afib
While more than half of eligible patients with cirrhosis and concurrent nonvalvular atrial fibrillation did not receive anticoagulation between 2012 and 2019, use of direct oral anticoagulants (DOACs) increased substantially during that time, a recent study found.
https://acpinternist.org/weekly/archives/2023/01/17/4.htm
17 Jan 2023
Risk of re-infection, benefits of anticoagulation, cause of sex differences among COVID-19 research
Researchers published evidence of re-infection with SARS-CoV-2, anticoagulation was associated with halved inpatient mortality, recommendations were made on pulmonary embolism in COVID-19, and a study attributed differences in men's and women's outcomes to T cells.
https://acpinternist.org/weekly/archives/2020/09/01/2.htm
1 Sep 2020
COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://acpinternist.org/weekly/archives/2021/06/15/1.htm
15 Jun 2021
Non-vitamin K oral anticoagulants appear superior to vitamin K antagonists in early-stage CKD
An accompanying editorial said that the current review supports a superior benefit profile of non-vitamin K oral anticoagulants (NOACs) in patients with atrial fibrillation and early-stage chronic kidney disease (CKD).
https://acpinternist.org/weekly/archives/2019/07/16/2.htm
16 Jul 2019
Anticoagulation not superior to placebo for calf DVT in low-risk patients, may increase bleeding risk
The randomized, double-blind, placebo-controlled trial examined a composite measure of extension of calf deep venous thrombosis (DVT) to proximal veins, contralateral proximal DVT, and symptomatic pulmonary embolism in a modified intention-to-treat population.
https://acpinternist.org/weekly/archives/2016/11/15/6.htm
15 Nov 2016